Johnson & Johnson

MagazineApple tops the 2026 World’s Most Admired Companies list—finishing No. 1 for the 19th year in a row
By Matthew Heimer and Scott DeCarloJanuary 21, 2026

LawJohnson & Johnson hit with another giant asbestos-talcum powder verdict: $65.5 million in Minnesota
By The Associated PressDecember 21, 2025

NewslettersWhy big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
By John KellNovember 19, 2025

AICompanies need to take a human-centric approach to AI, experts say, as executives try to shift from experimentation to implementation
By Angelica AngNovember 17, 2025

By Emma BurleighMarch 12, 2025

By John KellJanuary 29, 2025

MindFDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
By Beth GreenfieldJanuary 22, 2025

By Ruth Umoh and Natalie McCormickDecember 17, 2024

By Emma BurleighJuly 15, 2024

By Indrani SenJune 16, 2024

FinanceJohnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
By Will DanielMay 1, 2024

By John KellApril 3, 2024
Most Popular





